LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy

Lingjuan Sun(Ministry of Education of the People's Republic of China), Peixiang Lan(Ministry of Education of the People's Republic of China)
Journal for ImmunoTherapy of Cancer
January 1, 2024
Cited by 10


Related Papers